Critical Resources and CSIRO to collaborate on DSD battery technology
Critical Resources has received co-funding to support a collaborative research project with the CSIRO to support DSD battery technology.
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results
| ACG | Appendix 3B - Entitlements Issue | 24/04/18 | ||
| ACG | Underwritten Rights Issue Prospectus Lodged with ASIC | PRICE SENSITIVE | 23/04/18 | |
| ACG | Oversubscribed Capital Raising to Fast Track New Strategy | PRICE SENSITIVE | 23/04/18 | |
| ACG | Trading Halt | PRICE SENSITIVE | 19/04/18 | |
| ACG | Final Director's Interest Notice - D Brookes | 05/04/18 | ||
| ACG | Change to Board of Directors | 03/04/18 | ||
| ACG | Investor Presentation | 14/03/18 | ||
| ACG | AtCor Announces First Steps in Major Strategic Repositioning | PRICE SENSITIVE | 14/03/18 | |
| ACG | Resignation of CFO/Company Secretary | 06/03/18 | ||
| ACG | Half Yearly Report and Accounts | PRICE SENSITIVE | 28/02/18 | |
| ACG | AtCor's XCEL device clinically validated in 3rd party study | PRICE SENSITIVE | 23/01/18 | |
| ACG | Chairman's address to 2017 AGM | PRICE SENSITIVE | 30/11/17 | |
| ACG Appendix 3B - Entitlements Issue | |||
| 24/04/18 | |||
| ACG Underwritten Rights Issue Prospectus Lodged with ASIC | |||
| 23/04/18 | PRICE SENSITIVE | ||
| ACG Oversubscribed Capital Raising to Fast Track New Strategy | |||
| 23/04/18 | PRICE SENSITIVE | ||
| ACG Trading Halt | |||
| 19/04/18 | PRICE SENSITIVE | ||
| ACG Final Director's Interest Notice - D Brookes | |||
| 05/04/18 | |||
| ACG Change to Board of Directors | |||
| 03/04/18 | |||
| ACG Investor Presentation | |||
| 14/03/18 | |||
| ACG AtCor Announces First Steps in Major Strategic Repositioning | |||
| 14/03/18 | PRICE SENSITIVE | ||
| ACG Resignation of CFO/Company Secretary | |||
| 06/03/18 | |||
| ACG Half Yearly Report and Accounts | |||
| 28/02/18 | PRICE SENSITIVE | ||
| ACG AtCor's XCEL device clinically validated in 3rd party study | |||
| 23/01/18 | PRICE SENSITIVE | ||
| ACG Chairman's address to 2017 AGM | |||
| 30/11/17 | PRICE SENSITIVE | ||